Adaptive Biotechnologies Corp (ADPT) stock news · rev $277.0M
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
This ADPT news page leads with what Adaptive Biotechnologies Corp filed — not a scraped headline mill.
No cached 8-K sentence for ADPT yet. We will not pad this page with generic market recap.
Latest reported ADPT revenue for 2025-12-31 was $277.0M. Net income was -$59.5M. Revenue was up 54.8% from 2024-12-31 to 2025-12-31. ADPT currently screens at market cap $2.69B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADPT stock page; for the tape open the quote page.
ADPT stock news FAQ
What are ADPT's latest revenue and net income?
Latest cached Adaptive Biotechnologies Corp (ADPT) revenue for Dec 31, 2025 was $277.0M. Net income was -$59.5M. Statements: https://lician.com/financials/adpt
How did ADPT revenue change from the prior cached period?
Cached Adaptive Biotechnologies Corp (ADPT) revenue was up 54.8% from $179.0M (Dec 31, 2024) to $277.0M (Dec 31, 2025). Statements: https://lician.com/financials/adpt
What is ADPT's market cap?
Adaptive Biotechnologies Corp (ADPT) market cap is $2.69B on the latest cached fundamentals snapshot.
What kind of company is ADPT?
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Where is ADPT stock news listed?
Cached stock news for Adaptive Biotechnologies Corp (ADPT) is listed at https://lician.com/news/adpt. Filings: https://lician.com/sec/adpt
Not investment advice.